Engraftment of enteric neural progenitor cells into the injured adult brain by Jaime Belkind-Gerson et al.
Belkind‑Gerson et al. BMC Neurosci  (2016) 17:5 
DOI 10.1186/s12868‑016‑0238‑y
RESEARCH ARTICLE
Engraftment of enteric neural progenitor 
cells into the injured adult brain
Jaime Belkind‑Gerson1,4*, Ryo Hotta2, Michael Whalen1, Naema Nayyar3, Nandor Nagy2, Lily Cheng2, 
Aaron Zuckerman2, Allan M. Goldstein2,4† and Jorg Dietrich3†
Abstract 
Background: A major area of unmet need is the development of strategies to restore neuronal network systems and 
to recover brain function in patients with neurological disease. The use of cell‑based therapies remains an attrac‑
tive approach, but its application has been challenging due to the lack of suitable cell sources, ethical concerns, and 
immune‑mediated tissue rejection. We propose an innovative approach that utilizes gut‑derived neural tissue for cell‑
based therapies following focal or diffuse central nervous system injury.
Results: Enteric neuronal stem and progenitor cells, able to differentiate into neuronal and glial lineages, were iso‑
lated from the postnatal enteric nervous system and propagated in vitro. Gut‑derived neural progenitors, genetically 
engineered to express fluorescent proteins, were transplanted into the injured brain of adult mice. Using different 
models of brain injury in combination with either local or systemic cell delivery, we show that transplanted enteric 
neuronal progenitor cells survive, proliferate, and differentiate into neuronal and glial lineages in vivo. Moreover, 
transplanted cells migrate extensively along neuronal pathways and appear to modulate the local microenvironment 
to stimulate endogenous neurogenesis.
Conclusions: Our findings suggest that enteric nervous system derived cells represent a potential source for tissue 
regeneration in the central nervous system. Further studies are needed to validate these findings and to explore 
whether autologous gut‑derived cell transplantation into the injured brain can result in functional neurologic 
recovery.
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Background
Diseases of the nervous system belong to the most chal-
lenging maladies and have been recognized as one of the 
greatest threats to public health [1–5]. With a current 
lack of effective therapies for most neurological disor-
ders, such as neurodegenerative diseases, traumatic brain 
injury, or long-term neurotoxicity from cancer therapy, 
and a steadily growing aging population with increasing 
prevalence of neurological disorders, there is an urgent 
need to develop strategies for nervous system repair.
Neural plasticity and nervous system regeneration in 
the setting of injury or disease is dependent on the activ-
ity of neural stem and progenitor cells that reside in a spe-
cialized, regulatory neurovascular environment [6–11]. 
Optimizing the cellular and molecular factors that con-
trol the neural stem cell niche has evolved as an attractive 
strategy to promote central nervous system (CNS) repair 
following focal and diffuse brain injury [12]. However, the 
damaged central nervous system has a limited capacity 
for endogenous regeneration. Therefore, exogenous stem 
cell-based therapies remain a promising avenue to pro-
mote tissue and functional repair [13–15]. Experimen-
tal studies designed to transplant exogenous neural cells 
into the injured CNS have largely failed due to multiple 
reasons, including technical and ethical factors regarding 
the source of donor cells, immune-mediated transplant 
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rejection, and insufficient integration of transplanted 
cells into the host cellular network [16, 17].
Identifying an easily accessible, autologous, and reliable 
source of neural progenitor cells would address many of 
the current challenges and might be useful in the treat-
ment of a wide range of neurologic disorders. The objec-
tive of this study was to test the hypothesis that neural 
progenitor cells derived from the enteric nervous system 
(ENS) could have a potential role in CNS repair. We and 
others have previously shown that enteric neuronal stem 
and progenitor cells (ENSCs) can be successfully isolated 
from the postnatal ENS, propagated in vitro, and trans-
planted into the gut in  vivo [18–20]. Building on this 
knowledge, we transplanted gut-derived enteric neural 
progenitor cells into brain-injured mice.
We demonstrate that following both systemic and local 
administration, transplanted cells (1) home to neurogenic 
niches, (2) survive and differentiate into neuronal and 
glial lineages, and are able to (3) stimulate endogenous 
neurogenesis. These results support the potential use of 
autologous gut-derived neural tissue for cell replacement 
therapy in the injured CNS.
Methods
Animals
The Institutional Animal Care and Use Committee of 
the Massachusetts General Hospital approved all experi-
ments. We used two strains of genetically engineered ani-
mals as the source of donor cells to facilitate their in vivo 
tracking based on the expression of fluoresecent proteins: 
Actb-DsRed mice (strain Tg(CAG-DsRed*MST)1Nagy/J; 
Jackson Labs Stock #005441) were purchased from the 
Jackson Laboratory. All cells in Actb-DsRed mice are flu-
orescently labeled [21]. We also used transgenic Nestin-
GFP mice, in which GFP expression is controlled under 
the Nestin promoter [22]. Nestin-GFP mice were used as 
donor mice initially, but in light of better breeding effi-
ciency, we used Actb-DsRed donor mice in later experi-
ments. Recipient mice were wild-type C57BL/6.
Isolation and propagation of ENSCs in vitro
Mice were sacrificed on postnatal day 14-21 (P14-21), 
and the gastrointestinal tract from duodenum to anus 
was removed. The longitudinal muscle-myenteric plexus 
(LMMP) layer was separated and dissociated with dis-
pase (250  μg/ml; StemCell Technologies, Vancouver, 
Canada) and collagenase XI (1  mg/ml; Sigma Aldrich, 
St. Louis, MO, USA) at 37 °C for 1 h. The cell suspension 
was passed through a 40μm cell strainer and cultured 
at a density of 50,000 cells/mL in proliferation medium, 
consisting of Neurocult NSC Basal Medium (StemCell 
Technologies) supplemented with 20  ng/ml epidermal 
growth factor (EGF; StemCell Technologies) and 10 ng/
ml basic fibroblast growth factor (bFGF; StemCell Tech-
nologies), 0.0002 % Heparin (StemCell Technologies) and 
100U/ml Penicillin–Streptomycin (Life Technologies) for 
7–10  days to form enteric neurospheres. Neurospheres 
were passaged every 7–10  days with gentle Accutase 
(StemCell Technologies) dissociation followed by re-plat-
ing in culture medium containing conditioned medium 
(1:2 mix). ENSCs retain the capacity to form neuro-
spheres following up to five passages. For consistency, we 
used secondary neurospheres throughout this study.
To induce differentiation, neurospheres were dissoci-
ated with Accutase (StemCell Technologies) then passed 
though a 40  μm cell strainer and plated at 50,000  cells/
mL on glass-bottom chamber slides coated with 20 mg/
mL fibronectin (Biomedical Technologies, Ward Hill, 
MA, USA). Cells were cultured for 7 days in NeuroCult 
NSC Differentiation Medium (StemCell Technologies) 
prior to immunohistochemistry.
Brain injury models
Closed head injury (concussion model)
Mice were injured daily for 5 consecutive days, and 
transplanted into mice 3  days after the last injury. Dur-
ing injury, mice were anesthetized with 4 % isoflurane for 
45 s, grasped by the tail, and placed prone. The head of 
the animal was placed directly beneath the opening of a 
metal tube conduit. A 54-g metal bolt was dropped onto 
the midline of the head from a height of 38 inches. Sham-
injured mice were subjected to anesthesia but no weight 
drop.
Radiation injury
Mice were treated with either focal brain or whole body 
irradiation. For focal brain irradiation, the mouse body 
was protected with a customized lead shield and irradia-
tion administered to anesthetized mice as a single frac-
tion of 10 Gy using a Cs-irradiation source. Whole body 
irradiation was performed using a sublethal dose of 5 Gy 
in a similar fashion.
Cell transplantation
Prior to transplantation, dissociated ENSCs were pulsed 
for 2–4  h with 10  µM BrdU (3.3  µg/ml) to determine 
in vivo DNA synthesis as a surrogate marker for cell pro-
liferation. For cell transplantation directly into the brain, 
4–6 week-old wild-type mice were anesthetized with iso-
flurane and ENSCs (5000 cells per recipient) were stereo-
tactically injected into various brain regions using a Kopf 
stereotaxic frame (David Kopf Instruments; Tujunga, CA, 
USA). Injected regions included the lateral subventricu-
lar zone (SVZ) (coordinates: AP 1.0  mm, ML 1.0  mm, 
DV 2.1 mm), the dentate gyrus (DG) of the hippocampus 
(coordinates: AP −1.70 mm, ML 0.70 mm, DV 2.04 mm), 
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and the left lateral ventricle (LV) (coordinates: AP 0 mm, 
ML 1 mm, DV 2.5 mm). Systemic cell transplantation was 
performed via tail vein injection of ENSCs (100–400  k 
cells per recipient, depending on the experiment).
Immunofluorescence
Cells or tissues were fixed, washed, and permeabelized 
with 0.1  % Triton X-100 for 30  min and then exposed 
to the following primary antibodies: mouse anti-Tuj1 
(1:100, Covance, Dedham, MA, USA), mouse anti-Hu 
C/D (1:100, Life Technologies, Carlsbad, CA, USA), 
rabbit anti-p75 (1:500, Promega, Madison, WI, USA), 
rabbit anti-Sox2 (1:50, Abcam, Cambridge, MA, USA), 
rabbit anti-Doublecortin (1:250, Abcam), rabbit anti-
Olig2 (1:250, Millipore, Billerica, MA), goat anti-GFAP 
(1:500, Abcam), goat anti-GFP (1:400, Rockland, Limer-
ick, PA, USA). Secondary antibodies included goat anti-
mouse IgG Alexa Fluor 546, goat anti-rabbit Alexa Fluor 
488, donkey anti-goat Alexa Fluor 488, donkey anti-goat 
Alexa Fluor 546, donkey anti-mouse Alexa Fluor 546, 
donkey anti-mouse Alexa Fluor 488, all from Life Tech-
nologies (Carlsbad, CA, USA). Cell nuclei were stained 
with DAPI (Vector Labs, Burlingame, CA, USA).
Confocal microscopy
Z-stack images were obtained with laser scanning confo-
cal microscopy using a Nikon A1R confocal microscope, 
providing high-resolution images of up to 4096 ×  4096 
pixels with a galvano scanner.
Results
Postnatal gut‑derived ENSCs can be isolated 
and propagated in culture
To determine whether ENSCs could serve as a potential 
source for CNS repair, the intestinal tract of 2–3  week-
old postnatal Actb-DsRed mice was removed and ENSCs 
isolated and propagated, as previously described [23, 24]. 
ENSCs are able to form neurospheres in culture and these 
spheres can be labeled with markers for enteric neuronal 
progenitors (Sox2 and p75) as well as neuronal (Tuj1) and 
glial (GFAP) markers (Fig. 1). We have previously shown 
that enteric neurospheres contain 37.3 ± 4.2 %; neurons 
and 27.6 ± 1.7 glial cells (Hotta et al. in press). Dissoci-
ated neurospheres give rise to Tuj1 + and GFAP + cells, 
consistent with neuronal and glial differentiation, respec-
tively (Fig. 1B, C, F, G).
Following intracerebral injection ENSCs survive 
and stimulate endogenous neurogenesis
To determine whether gut-derived neural progeni-
tor cells can survive after transplantation into the adult 
brain, ENSCs were prepared, pulsed with BrdU in vitro, 
and injected as a cell suspension (5000 cells in 3 µl vol-
ume) into various brain regions (lateral subventricular 
Fig. 1 In vitro characterization of multipotent, self‑renewing progenitor cells from the postnatal ENS. Enteric neurospheres derived from Actb‑
DsRed mouse colon express red fluorescent protein (A). Enteric neuronal stem/progenitor cells (ENSCs) within those neurospheres differentiate 
into neurons (B) and glia (C) that retain DsRed expression. Immunohistochemical characterization shows that cells within the neurospheres express 
markers of neural progenitors (Sox2, D; P75, E), enteric neurons (Tuj1, F), and glial cells (GFAP, G)
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zone, dentate gyrus of the hippocampus, and lateral 
ventricle). In this pilot experiment, Nestin-GFP-labeled 
cells were used [22] with subsequent experiments using 
Actb-DsRed-labeled cells. Mice were sacrificed after 2 
and 4 weeks following transplantation (n = 5 per group). 
Immunohistochemistry identifies gut-derived GFP+ 
neural precursors in the brains of transplanted animals 
at both time points. Following injection into the lateral 
ventricle, cells were found along the inner lining of the 
ependymal layer of the ventricular system (Fig.  2B, C) 
and along the needle tract (not shown). GFP  +  cells 
were also seen in the brain parenchyma in and around 
Fig. 2 Survival and localization of ENSCs following intracerebral delivery. Nestin‑GFP+ ENSCs were injected into various brain regions and mice 
were analyzed at 2 weeks and 4 weeks post transplantation into the brain regions depicted (A). Transplanted cells were found in clusters (B) and 
monolayers (C) along the ventricular lining, and within the parenchyma of the hippocampus formation (D, F–H) and subventricular zone (E). BrdU 
labeling confirms survival of proliferating ENSCs (E). Differentiation into glial (E) and neuronal (F–H) phenotypes is also seen (F represents an inset 
from the same region as G, with Tuj1 as a marker of mature neurons). Increased numbers of endogenous doublecortin+ neurons within the dentate 
gyrus are identified in close proximity to GFP+ transplanted cells (G, arrow)
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the dentate gyrus following transplantation into the hip-
pocampal region (Fig.  2D–G), where rare transplanted 
cells were identified to display a branched morphology 
with apparent integration into the granular cell layer 
of the dentate gyrus (Fig.  2D). This tissue integration 
was only observed at 4 weeks, but not at 2 weeks after 
transplantation.
Cells co-expressing both GFP and BrdU were identi-
fied, suggesting that proliferating ENSCs survive for at 
least 4 weeks after transplantation (Fig. 2E). A subpopu-
lation of transplanted cells co-expressed doublecortin, a 
marker of immature neurons (Fig.  2F–H), and GFAP, a 
glial cell marker (Fig. 2E). Interestingly, enhanced endog-
enous neurogenesis, as evidenced by focally increased 
doublecortin expression, was observed in the granular 
cell layer of the dentate gyrus in close proximity to the 
location of the transplanted cells (Fig. 2G).
ENSCs delivered systemically home to the injured brain
Based on our initial experiments employing cell delivery 
via intracerebral injection, we asked whether systemi-
cally delivered cells would be able to home to the sites of 
injury. We focused on clinically relevant injury models, 
including an injury model caused by concussion (closed 
head injury) and an injury model caused by irradiation. 
Following concussion injury, as described in Methods, 
Actb-DsRed  +  ENSCs were injected systemically via 
tail vein (400,000 cells in 200 µL; n = 3). Controls were 
injected with cell-free media (n =  2). All mice survived 
until sacrifice at 10 weeks post transplantation. Systemi-
cally administered ENSCs were identified 10 weeks post-
transplantation. We found ENSCs homing to the injury 
site at the cortical surface, as shown in Fig.  3B. Trans-
planted cells were also identified within the brain paren-
chyma with apparent migration along white matter tracts 
(Fig.  3A–C), connecting the injury site with the ipsilat-
eral dentate gyrus (Fig. 3B–G). A significant increase in 
resident doublecortin  +  cells, suggestive of increased 
endogenous neurogenesis, was observed predominantly 
in areas adjacent to where transplanted cells were iden-
tified (Fig.  3E–H). As shown in Fig.  3E, endogenous 
doublecortin expression was more pronounced in areas 
where DsRed  +  cells were located (upper part of the 
image, Fig. 3E), but not in areas devoid of DsRed + cells 
(lower part of the image, Fig. 3E). In this experiment, we 
were not able to detect DsRed  +  cells that co-labeled 
with doublecortin.
To determine whether systemically delivered cells also 
home to other organs, we analyzed lung tissue at 24  h 
and up to 75 days post-injection. DsRed + ENSCs were 
found in clusters in the lung at 24  h (Additional file  1: 
Figure S1), but were not seen at 75 days (not shown).
Systemically delivered ENSCs are identified throughout the 
brain following radiation injury
Based on our observations we hypothesized that focal 
brain injury induced by either needle injury or concus-
sion resulted in significant neural and vascular tissue 
damage, perhaps facilitating the entry of ENSCs into the 
brain parenchyma.
To explore whether systemically delivered ENSCs 
are able to enter the central nervous system in the set-
ting of radiation injury, considered less traumatic to the 
integrity of brain tissue, we performed an experiment 
using a whole-body (including brain) radiation injury. 
A sub lethal radiation dose of 5  Gy was administered 
to mice and ENSCs (100,000 cells in 400  µL) delivered 
via tail vein 48  h later. Control animals were irradiated 
and treated with saline injection via tail vein. Animals 
were examined 14  days following cell delivery. Notably, 
DsRed +  cells were identified in multiple brain regions, 
and were especially enriched in the germinal zones of the 
brain (SVZ and DG) and large white matter tracts. Spe-
cifically, cells were found in the granular cell layer of the 
dentate gyrus (Fig. 4B), the corpus callosum, one of the 
largest white matter tracts in the central nervous system 
(Fig.  4C), the choroid plexus, a highly vascularized tis-
sue within the ventricular system (Fig. 4D), and the sub-
ependymal layer of the lateral ventricle (Fig. 4E–G).
Based on the findings of this experiment, we modified 
our experimental setting to reflect a more relevant clinical 
scenario. As whole body irradiation is mainly reserved for 
patients treated with bone marrow transplantation and is 
less commonly used in clinical practice, we modified our 
experimental design to use focal brain irradiation instead, 
which is frequently applied to patients with brain cancer. 
The brain of mice was irradiated with 10 Gy in a single frac-
tion and ENSCs (400,000 cells in 400  µL) were delivered 
via tail vein 48 h later. One experimental group (brain irra-
diation and ENSC delivery, n = 3) was compared to three 
control groups (irradiation without ENSCs, n = 3; no irradi-
ation with ENSCs, n = 3; and no irradiation without ENSCs, 
n = 3). Mice were analyzed 28 days after cell delivery. The 
results confirmed our preliminary findings, showing the 
presence of transplanted cells in germinal zones, including 
the subependymal layer of the ventricular zone (Fig. 5B–D) 
and the dentate gyrus (Fig. 5I), as well as within white mat-
ter tracts (Fig. 5F). Interestingly, many of the transplanted 
cells identified in mice analyzed at 28 days co-labeled with 
anti-Hu, a mature neuronal marker. Notably, in non-irradi-
ated animals, DsRed + cells were not readily detectable in 
the brain. We also did not identify the presence of intrave-
nously-delivered ENSCs in the intestine, suggesting that 
tissue injury may be a prerequisite for the homing of sys-
temically-delivered cells.
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Discussion
The main objective of this study was to determine whether 
neural progenitor cells derived from the ENS could survive 
in the adult mammalian brain after transplantation and 
could have a potential role in repair of the injured CNS. 
We found that transplanted ENSCs survive, proliferate, 
and differentiate into neuronal and glial lineages in  vivo. 
Moreover, transplanted cells migrate extensively along 
pre-existing pathways and modulate the local microenvi-
ronment to stimulate endogenous neurogenesis.
We recently showed that Nestin-expressing neural 
progenitor cells can be isolated from the intestine and 
propagated in vitro to give rise to neurospheres capable 
of differentiating into neuronal and glial lineages [23]. 
These findings were confirmed in the present study. We 
have also previously shown that these neurospheres 
can generate enteric neurons upon transplantation into 
aneural embryonic hindgut [23]. Interestingly, brain- 
and gut-derived neurospheres appear to possess pheno-
typically similar features, including the ability to form 
Fig. 3 Following concussion injury, ENSCs cluster around injured brain parenchyma, migrate to neurogenic niches, and induce focal neurogenesis. 
Concussion injury was induced over 5 days, ENSCs delivered systemically 3 days later, and brains analyzed after 10 weeks. Brain regions shown in 
each panel are indicated in (A). ENSCs are identified at the site of brain injury, both at the cortical surface (B, thin arrows) and in the parenchyma 
(B–G). ENSCs appear to be migrating from the injury site toward the ipsilateral dentate gyrus (B, thick arrows). Doublecortin + endogenous neurons 
are observed in increased numbers in the region of the transplanted cells in the dentate gyrus (E–G) and at the cortical surface (H, arrows highlight 
transplanted ENSCs adjacent to endogenous doublecortin + neurons)
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Fig. 4 Systemically delivered ENSCs home to the brain following whole body radiation. ENSCs were delivered systemically 2 days after whole body 
radiation and mice analyzed at 14 days. Brain regions shown in each panel are indicated in (A). DsRed + cells are present in the subgranular layer 
of the dentate gyrus, alongside endogenous doublecortin + (white) neurons (B). Transplanted cells are also found within large white matter tracts 
bordering the subventricular zone (C), choroid plexus (D), and subependymal layer of the subventricular zone (E–G)
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Fig. 5 ENSCs home to the brain and undergo neuronal differentiation after focal brain irradiation. Mice were subjected to focal brain irradiation, 
transplanted with DsRed + ENSCs via tail vein 2 days later, and analyzed at 28 days. Brain regions shown in each panel are indicated in (A). Trans‑
planted cells are present in the subventricular zone and co‑express Hu, consistent with neuronal differentiation (B–E, G, H). DsRed + cells are also 
seen in the dentate gyrus (I), in close proximity to Olig2 + oligodendrocytes (F)
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dense neuroglial networks in culture and the expression 
of similar markers of pluripotency [23]. However, their 
functional properties following transplantation in  vivo 
have not yet been compared. Based on our previous suc-
cess in isolating, culturing, and transplanting gut-derived 
neurospheres, and their phenotypic similarities to brain-
derived neurospheres, we initiated the present proof-of-
principle study.
One of the current challenges compromising the suc-
cess of cell transplantation strategies for the injured 
central nervous system has been immune rejection of 
transplanted cells by the host organism. A particular 
strength of the current approach was the use of enteric-
derived neuronal progenitors, aiming at an elimination 
of detrimental immune rejection mechanisms if used in 
an autologous fashion. In addition, cell delivery to injured 
tissue typically relies on direct donor cell injection, an 
invasive procedure that results in local tissue damage and 
other morbidity [25, 26]. In a recent paper, ENS progeni-
tor cells were injected into the hippocampus of irradiated 
mice, but cell survival was poor and no differentiation 
was observed [26]. Based on these findings, it remains 
unclear whether direct tissue injury and local inflam-
mation with microglial activation caused by injection, 
as reported by Osman et  al. [26], could hinder cell sur-
vival and integration into the host. In the present study, 
we tested the feasibility of systemic delivery to the injured 
nervous system. To further validate the clinical relevance 
and practicality of this approach, we used three different 
injury models, including needle injury, concussion injury, 
and brain irradiation.
Our findings suggest that gut-derived neural progeni-
tor cells, genetically engineered to express fluorescent 
proteins, can be successfully transplanted into the injured 
adult brain. These cells home to sites of injury follow-
ing systemic cell delivery. Transplanted cells were able 
to survive at least 10  weeks, proliferate as reflected by 
BrdU incorporation, and exhibited both neuronal and 
glial immunophenotypes in  vivo [27]. The ENSCs we 
detected appeared to be anatomically integrated into the 
tissue as shown in Figs. 2 and 4, although their functional 
integration into the neuronal network remains unknown. 
We noted that some fluorescently transplanted cells 
were negative for both neuronal and glial markers. The 
fate of these may include either mesenchymal cell types 
or undifferentiated precursors, as shown by others [28, 
29]. Characterizing and optimizing temporal and spatial 
neuroglial differentiation in the host tissue is a critically 
important goal.
Notably, transplanted cells appeared to modulate the 
endogenous niche environment of germinal zones in the 
adult brain where increased endogenous neuronal dif-
ferentiation was identified. While injury alone is able to 
stimulate endogenous neurogenesis [30] we observed sig-
nificantly increased numbers of doublecortin + neurons 
in close proximity to transplanted ENSCs. Furthermore, 
while direct needle injection causes injury along the nee-
dle tract and could account for endogenous neurogenesis 
as a response to structural tissue damage, we observed a 
similar pattern of stimulated endogenous neurogenesis 
following systemic cell delivery in the concussion model 
(Fig. 3). In our models, the needle injury did not induce 
any notable increase in neurogenesis in non-transplanted 
controls and no increase in neurogenesis was observed 
along the needle tract. Furthermore, the area of neuro-
genesis was restricted to the site of transplanted ENSCs. 
Thus, the co-location of newly generated doublecortin-
expressing endogenous neurons and the transplanted 
ENSCs is suggestive of cell transplantation associated 
endogenous neurogenesis, although this remains to be 
verified. Importantly, brain or whole body irradiation 
does not lead to any gross alteration in brain structure in 
the time periods we studied, although disruption of the 
functional integrity of the blood–brain barrier does occur 
[31]. Similarly, the concussion model employed does not 
lead to any gross alteration in brain structure [32].
In the present study we used a rodent allogenic trans-
plant model, but our findings support the hypothesis 
that in humans, autologous gut-derived neural cells may 
offer a promising cell source for transplantation into the 
injured CNS. While ENSCs can be isolated from all intes-
tinal segments and using donors of all ages [18, 33, 34], of 
particular clinical interest are mucosal/submucosal endo-
scopic biopsies as a strategy to harvest gut-derived pro-
genitor cells. These techniques have been used to isolate 
and expand ENSc populations [35] and may provide a 
suitable source of cells derived from a minimally invasive 
intervention. Thus our data provide support for further 
studies to investigate whether small intestinal biopsies 
from adult donors can serve as a cell source for ENSCs 
transplantation. In order to validate the functional rele-
vance of this proposed repair strategy, studies in disease-
specific preclinical models are needed.
Our findings raise a number of questions that remain 
unanswered: What are the spatial and temporal dynam-
ics of transplanted cells? What is the proportion of trans-
planted cells that survive and for how long? What is the 
extent of neuronal and glial differentiation in each model 
system, and what is the optimal timing for cell transplan-
tation after injury to yield maximal benefit? What is the 
mechanism by which transplanted cells might stimulate 
brain plasticity (e.g., cell integration into the host net-
work system and production of neuroprotective factors)? 
Perhaps most importantly, do transplanted cells result 
in functional recovery? While the current study was 
not designed to address these important questions or to 
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provide quantitative data, our findings suggest that the 
use of autologous intestinal neural tissues for CNS repair 
might be a feasible strategy that warrants further investi-
gation and could represent a promising avenue for rapid 
translation into the clinical arena.
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